Technical Articles
neuroprotection
What Is CNTF: Neuroprotective Mechanisms, Retinal Evidence and Activity Assays
CNTF is an IL-6 family neurotrophic cytokine acting through CNTFR/gp130/LIFR. This article covers its neuroprotective mechanisms, retinal ganglion cell evidence and activity determination with recombinant rat CNTF.
View details
- Cell Biology
- CNTF
- ciliary neurotrophic factor
- CNTFR
- gp130
- neuroprotection
- retinal ganglion cell
- activity assay
- UA040187
Recombinant Human EPO: Why a Hematopoietic Hormone Keeps Showing Up in Vascular and Neural Research
EPO is a four-helix-bundle glycoprotein hormone acting through the EPOR-JAK2/STAT5 axis. This article explains erythroid development, glycosylation-driven molecular-weight heterogeneity and non-hematopoietic activities in vascular and neural research
View details
- Cancer
- EPO
- EPOR
- JAK2
- STAT5
- erythroid progenitor
- glycosylation
- CHO expression
- neuroprotection
- UA040004
Study on the Mechanism of BDNF Protein in the Neuroprotective Effects of Acupuncture
The neuroprotective effects of acupuncture are closely related to changes in various signaling pathways, and accumulating evidence suggests that endogenous biological mediators such as members of the neurotrophic protein family are involved.
View details
- Neuroscience
- BDNF Protein
- Neuroprotection
- Signaling Pathway
Is EPO More Than Just a Blood Booster? How Does It Influence Cancer and Neurological Diseases?
EPO is a cytokine with complex and potent functions. The in-depth understanding of its mechanisms has not only driven innovations in anemia treatment but has also opened up new perspectives for treating neurological diseases and comprehending tumor biology. In the future, developing EPO drugs with higher tissue specificity will be a crucial direction for achieving precision medicine.
View details
- Cancer
- EPO Protein
- Erythropoietin
- Renal Anemia
- Recombinant Human EPO
- HIF-PHI
- Cancer-Related Anemia
- Neuroprotection
- Polycythemia Vera
- JAK2 Mutation
- 1










